Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →🤖 ML Fraud Detection Score: 87%
Machine learning model identifies prescribing patterns consistent with confirmed fraud cases. This is a statistical indicator, not an accusation.
Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
11,719
Total Claims
$1.2M
Drug Cost
561
Beneficiaries
$2,157
Cost/Patient
Risk Score Breakdown 18/100
Score components are additive. Read full methodology
Peer Comparison vs. 106,889 Family Practice providers
+83%
Opioid rate vs peers
4.7% vs 2.6% avg
+102%
Cost per patient vs peers
$2,157 vs $1,068 avg
+62%
Brand preference vs peers
14.6% vs 9.0% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
Opioid Prescribing
4.7%
Opioid Rate
552
Opioid Claims
$10K
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
Brand: 1,701 claims · $1.0M
Generic: 9,957 claims · $159K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 201 | $149K |
| Semaglutide | 86 | $99K |
| Empagliflozin | 118 | $95K |
| Dapagliflozin Propanediol | 83 | $73K |
| Sacubitril/Valsartan | 72 | $65K |
| Finerenone | 73 | $61K |
| Tirzepatide | 51 | $57K |
| Mirabegron | 99 | $54K |
| Dulaglutide | 35 | $37K |
| Sitagliptin Phosphate | 50 | $35K |
| Insulin Glargine,hum.Rec.Anlog | 35 | $32K |
| Fluticasone/Umeclidin/Vilanter | 40 | $29K |
| Insulin Degludec | 22 | $27K |
| Rivaroxaban | 37 | $23K |
| Semaglutide | 14 | $18K |
Prescribing Profile
Patient Profile
72
Avg Age
50%
Female
1.08
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About